Author: Brittney Wheeler

A comprehensive analysis of federal data by researchers at Washington University School of Medicine shows people who have had COVID-19 are at an elevated risk of developing neurological conditions within the first year after infection.

An international phase 3 clinical trial for a drug developed to treat a rare, inherited form of amyotrophic lateral sclerosis (ALS) showed that it reduced molecular signs of the fatal disease, but at six months did not improve motor control and muscle strength, according to Washington University School of Medicine researchers.

Ervin Scholars alumnae Brittany Packnett Cunningham and Morgan DeBaun will give a talk as part of the 35th anniversary celebration of the John B. Ervin Scholars Program Sept. 30.

Siteman Cancer Center and the University of Missouri will collaborate on cancer research, with the aim to improve care throughout Missouri.

Thomas De Fer, MD, and Victoria J. Fraser, MD, both of the School of Medicine, have been awarded mastership in the American College of Physicians, one of the highest honors available to internists.

Images from on and around the Washington University campuses.

Washington University School of Medicine’s Jeffrey Gordon, MD, has received the inaugural David and Beatrix Hamburg Award for Advances in Biomedical Research and Clinical Medicine from the National Academy of Medicine. Gordon is regarded as the father of the field of microbiome research.

St. Louis CITY Soccer Club has chosen physicians with Washington University Orthopedics as the club’s official team doctors and BJC HealthCare as medical services provider.

Benjamin Garcia, the Raymond H. Wittcoff Distinguished Professor and head of the Department of Biochemistry and Molecular Biophysics at the School of Medicine, along with colleagues at the University of Pennsylvania, received a five-year $2.6 million grant from the National Institutes of Health (NIH) for a quantitative mass spectrometry project.

Washington University School of Medicine is joining the National Institutes of Health (NIH)’s Bridge2AI program, an estimated $130 million initiative. One project aims to develop a framework for using artificial intelligence to diagnose disease based on the sound of patients’ voices.